MedTrace Logo

A Drug Interaction Study of SLM0807 and HKB0701 in Healthy Subjects

NCT01039896 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2013-02-13

No results posted yet for this study

Summary

The aim of this study is to assess whether HKB0701 alters pharmacokinetics of SLM0807.

Conditions

Interventions

DRUG

Period I : SLM0807, Period II : HKB0701 and SLM0807

DRUG

Period I : HKB0710 and SLM0807, Period II : SLM0807

Sponsors & Collaborators

  • HK inno.N Corporation

    lead INDUSTRY

Principal Investigators

  • Jae Gook Shin, MD, ph D · Inje University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2009-07-31
Completion
2009-08-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01039896 on ClinicalTrials.gov